SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Terra Tech Corp (OTCMKTS:TRTC) released its 3Q2016 financial report for the quarter closing September 30, 2016. Derek Peterson, the CEO, commented that they are thrilled to witness their plan to expand company’s retail presence in core target industry boost top line growth, with quarterly revenue reaching $7 million in 3Q2016. It shows a 244% jump compared to the preceding year period.

The highlights

The results were boosted by sakes from the Blüm Oakland Dispensary and the ‘Western Las Vegas Blüm Dispensary’, both of which started in this year only. In 3Q2016, the company started the ‘South Decatur Boulevard Blüm Dispensary’, which is based in Nevada. Moreover, with the passing of ballots to approve recreational cannabis in California and Nevada, they are well-positioned to boost growth as the market opportunity expands.

The CEO added that in addition to creating a retail presence in California and Nevada, they remain focused on enhancing brand recognition of patented IVXX-branded line of medical cannabis products. They believe that IVXX products are becoming a trusted and renowned medical cannabis brand in the nation, which will offer the company’s brand ‘staying power’ as the cannabis evolves and new players venture into the market.

Terra Tech’s Edible Garden division, which produces sustainably and local cultivated hydroponic foods, posted a strong performance, with revenues jump of 34% YoY for the third quarter. The distribution channels now comprise Wegmans Supermarket and the sales team projects this division to continue to offer steady cash flow to boost growth in the operations in the near term.

The financial performance

Total revenues for 3Q2016 came at $7 million compared to $2 million in the comparable period in 2015. It is a jump of 244% over the quarter closed September 30, 2015. The jump in third quarter revenues was mainly attributable to sales from the Blüm dispensary acquisition in Oakland, which closed in April, sales of IVXX cannabis offerings and Edible Garden goods sales. Third quarter revenues benefited from impressive sales reported by the Western, Las Vegas Blum dispensary.

Gross margin in 3Q2016 was nearly $1.3 million against gross margin of around $370,000 for the third quarter of FY2015.

SHARE
Previous articleWhat Is Going On With American Cannabis Company Inc (OTCMKTS:AMMJ)?
Next articleMarijuana Company Of America Inc (OTCMKTS:MCOA) Provides 4Q2016 Outlook
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.